Aanjaneya Lifecare IPO : Opening on 9th May 2011

by khalid on 03/05/2011 · 0 comments

Mumbai based Aanjaneya Lifecare Limited is entering into primary market with an Initial Public Offer (IPO) of 5,000,000 Equity Shares of Rs 10 each. This will constitute 39.76% of fully diluted post issue paid up capital of the company. The IPO is opening on 9th May 2011 and the shares will be available for subscription up to 12th May 2011. The premium of the issue will be decided through a 100% Book Building Process. The price band for the issue has been fixed at Rs 228 – Rs 240 Per Equity Share. The company is likely to raise around Rs 120.00 Crore through the issue at the upper level of price band. Aanjaneya Lifecare Limited is a pharmaceutical company engaged in manufacturing & marketing of Bulk Drugs, Finished Dosage Forms, Herbal Medicines, Inhalers, Lozenges and Animal Health.

The proceeds of the IPO are proposed to be utilized for setting up different plants, to expand existing R&D, to meet the expenses for branding and registration of products in the international markets, among others with expansion plans of about Rs 100 crore.

The equity shares offered through the IPO are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

IPO Summary :-
Issue Open : 9th May 2011 – 12th May 2011
Issue Type : 100% Book Built Issue IPO
Issue Size : 5,000,000 Equity Shares of Rs 10 each
Issue Size : Rs 114.00 – 120.00 Crore
Face Value : Rs 10 Per Equity Share
Issue Price : Rs 228 – Rs 240 Per Equity Share
Minimum Bid Quantity : 25 Shares (Rs.6000 with 1 Lot) @ upper level of price band
Maximum Bid Quantity : 825 Shares (Rs. 198000 with 33 Lots ) @ upper level of price band
Listing At : BSE, NSE

The Book running lead managers (BRLM) to the issue are Anand Rathi Securities Limited and IDBI Capital Market Services Limited.

Registrar of the Issue : Link Intime (India) Private Limited

Stay tuned to BelltheBull Blog for more on Aanjaneya Lifecare IPO !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: